Green Thumb Industries Inc. (CNSX: GTII)
Green Thumb Industries (GTI) is a consumer packaged hemp products and retailer that manufactures and distributes branded cannabis products including flowers, concentrates, foods and themes under Beboe, Dogwalkers, Dr. Solomon’s, Good Green, Incredibles, and RYTHM. The company also owns and operates a cannabis retailer called Rise.
Green Thumb operates in 15 US states, with 17 manufacturing facilities and several retail locations. The company experienced explosive growth after the legal recreational marijuana market in Illinois opened for operation at the beginning of 2020, and Green Thumb has the option to expand into more states as demand and industry grow, providing the company with new avenues for growth.
InnoCan Pharma (CNSX: INNO)
InnoCan Pharma is a specialized pharmaceutical company based in Israel that specializes in developing innovative delivery methods for CBD. The company is developing a CBD drug delivery platform based on a unique, controlled liposome in collaboration with Yissum, the commercial arm of the Hebrew University of Jerusalem, which it believes will lead to more effective and long-term therapeutic benefits.
InnoCan recently stated that the physicochemical characterization of its CBD Liposome medicinal product, which is an important part of the FDA’s application package, has been successfully completed. InnoCan is also working on a revolutionary and innovative exosome-based technology with Ramot at Tel Aviv University that uses CBD to target CNS indicators and the COVID-19 virus.
Furthermore, the company is seeking to commercialize veterinary drugs after discovering promising results in treating a variety of disorders in dogs. InnoCan currently holds more than 15 patents, and with exclusive and non-exclusive licensing agreements signed in 2021, the company’s technology commercialization continues to move in the right direction. InnoCan’s existing pipeline of technology and pharmaceutical products and solutions could provide significant value to investors in the future.
Innovative Industrial Real Estate Company (IIPR)
Innovative industrial properties is a self-advising real estate investment firm (REIT) that specializes in the acquisition, disposal, development and management of industrial property leased to experienced, state-licensed cannabis growers. The sale of real estate to Innovative Industrial gives the cannabis operator much-needed cash, helping alleviate a cash shortage for growing marijuana companies.
These lease agreements provide the company with a stable source of income. As with any REIT, Innovative Industrial distributes at least 90% of its taxable revenue, which makes it a good choice for income investors as well. As of April 28, the company owned 109 properties comprising approximately 8.1 million leasable square feet (including approximately 2.4 million leasable square feet under development or redevelopment) in 19 states.
Despite the challenges, the increasing demand for CBD for health and wellness applications is accelerating market expansion while the growing understanding of the medicinal benefits of CBD has become a reason for CBD regulators to be approved for various purposes. With more favorable legal action on the cards for the coming years, the cannabis sector appears to be well positioned for growth. Investing in the right cannabis company can help investors enjoy attractive returns in the future.